Emily Carpenter

Detection of Chromosome Abnormalities Pre–High-Dose Treatment in Patients Developing Therapy-Related Myelodysplasia and Secondary Acute Myelogenous Leukemia After Treatment for Non-Hodgkin’s Lymphoma

Debra M. Lillington, Ivana N. Micallef, Emily Carpenter et al. · Journal of Clinical Oncology · 2001 · 55 citations

Medicine, Hematology, Oncology +17

A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells

Bo Wang, Dongping Li, Rocio Rodriguez‐Juarez et al. · BMC Cancer · 2018 · 50 citations · Full text

Medicine, Molecular Biology, Oncology +17

A dual role of miR-22 modulated by RelA/p65 in resensitizing fulvestrant-resistant breast cancer cells to fulvestrant by targeting FOXP1 and HDAC4 and constitutive acetylation of p53 at Lys382

Bo Wang, Dongping Li, Jody Filkowski et al. · Oncogenesis · 2018 · 47 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder

Emily Carpenter, Verónica Valverde-Garduño, Alex Sternberg et al. · British Journal of Haematology · 2005 · 46 citations · Full text

Life Sciences, Genetics, Hematology +12

Early Diagnosis and Localization of Brain Tumors

Emily Carpenter · Radiology · 1926 · 20 citations

Medicine, Oncology, Radiology +9